Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings...
Sara Garcia Ratés, CSO at Neuro-Bio, will be representing Neuro-Bio together with members of other industries such Big Pharma in this collaboration of academia and industry. The board will provide advice and support to develop the University curriculum, initiate more...
The 4th edition of the Brain Innovation Days, organised by the European Brain Council, will take place on 13-14 November 2024 in Brussels, Belgium. The aim of the event is to bring the wider brain ecosystem together to foster dialogue,...
Baroness Greenfield spoke online at the Longevity Nation Conference on 28th October 2024, where she spoke about a novel mechanism underlying ageing. Click here to read more about the conference
On October 31, 2024, Baroness Susan Greenfield delivered a thought-provoking speech in the House of Lords on the critical impact of science and technology on the UK economy. She emphasized the need for enhanced investment in biotech, especially for tackling...
